-
2
-
-
0032190645
-
Echocardiographic and biochemical evaluation of the development and progression of carcinoid heart disease
-
Denney WD, Kemp WE Jr, Anthony LB, Oates JA, Byrd BF III: Echocardiographic and biochemical evaluation of the development and progression of carcinoid heart disease. J Am Coll Cardiol 1998; 32: 1017-1022.
-
(1998)
J Am Coll Cardiol
, vol.32
, pp. 1017-1022
-
-
Denney, W.D.1
Kemp Jr., W.E.2
Anthony, L.B.3
Oates, J.A.4
Byrd III, B.F.5
-
4
-
-
0037434851
-
Factors associated with progression of carcinoid heart disease
-
DOI 10.1056/NEJMoa021451
-
Møller JE, Connolly HM, Rubin J, Seward JB, Modesto K, Pellikka PA: Factors associated with progression of carcinoid heart disease. N Engl J Med 2003; 348: 1005-1015. (Pubitemid 36302245)
-
(2003)
New England Journal of Medicine
, vol.348
, Issue.11
, pp. 1005-1015
-
-
Moller, J.E.1
Connolly, H.M.2
Rubin, J.3
Seward, J.B.4
Modesto, K.5
Pellikka, P.A.6
-
5
-
-
0027415887
-
Carcinoid heart disease. Clinical and echocardiographic spectrum in 74 patients
-
Pellikka PA, Tajik AJ, Khandheria BK, Seward JB, Callahan JA, Pitot HC, Kvols LK: Carcinoid heart disease. Clinical and echocardiographic spectrum in 74 patients. Circulation 1993; 87: 1188-1196.
-
(1993)
Circulation
, vol.87
, pp. 1188-1196
-
-
Pellikka, P.A.1
Tajik, A.J.2
Khandheria, B.K.3
Seward, J.B.4
Callahan, J.A.5
Pitot, H.C.6
Kvols, L.K.7
-
6
-
-
0034854597
-
Prediction of prognosis by echocardiography in patients with midgut carcinoid syndrome
-
DOI 10.1046/j.0007-1323.2001.01798.x
-
Westberg G, Wängberg B, Ahlman H, Bergh CH, Beckman-Suurkula M, Caidahl K: Prediction of prognosis by echocardiography in patients with midgut carcinoid syndrome. Br J Surg 2001; 88: 865-872. (Pubitemid 32823842)
-
(2001)
British Journal of Surgery
, vol.88
, Issue.6
, pp. 865-872
-
-
Westberg, G.1
Wangberg, B.2
Ahlman, H.3
Bergh, C.H.4
Beckman-Suurkula, M.5
Caidahl, K.6
-
7
-
-
38549172237
-
Analysis of 150 Patients With Carcinoid Syndrome Seen in a Single Year at One Institution in the First Decade of the Twenty-First Century
-
DOI 10.1016/j.amjcard.2007.08.045, PII S0002914907019224
-
Bhattacharyya S, Toumpanakis C, Caplin ME, Davar J: Analysis of 150 patients with carcinoid syndrome seen in a single year at one institution in the first decade of the twenty-first century. Am J Cardiol 2008; 101: 378-381. (Pubitemid 351162970)
-
(2008)
American Journal of Cardiology
, vol.101
, Issue.3
, pp. 378-381
-
-
Bhattacharyya, S.1
Toumpanakis, C.2
Caplin, M.E.3
Davar, J.4
-
8
-
-
0036163671
-
Surgical pathology of carcinoid heart disease: A study of 139 valves from 75 patients spanning 20 years
-
Simula DV, Edwards WD, Tazelaar HD, Connolly HM, Schaff HV: Surgical pathology of carcinoid heart disease: a study of 139 valves from 75 patients spanning 20 years. Mayo Clin Proc 2002; 77: 139-147.
-
(2002)
Mayo Clin Proc
, vol.77
, pp. 139-147
-
-
Simula, D.V.1
Edwards, W.D.2
Tazelaar, H.D.3
Connolly, H.M.4
Schaff, H.V.5
-
9
-
-
14644392193
-
Prognostic indicators for carcinoid neuroendocrine tumors of the gastrointestinal tract
-
Rorstad O: Prognostic indicators for carcinoid neuroendocrine tumors of the gastrointestinal tract. J Surg Oncol 2004; 89: 151-160.
-
(2004)
J Surg Oncol
, vol.89
, pp. 151-160
-
-
Rorstad, O.1
-
10
-
-
0022005869
-
The carcinoid syndrome: Comparison of 21 necropsy subjects with carcinoid heart disease to 15 necropsy subjects without carcinoid heart disease
-
Ross EM, Roberts WC: The carcinoid syndrome: comparison of 21 necropsy subjects with carcinoid heart disease to 15 necropsy subjects without carcinoid heart disease. Am J Med 1985; 79: 339-354.
-
(1985)
Am J Med
, vol.79
, pp. 339-354
-
-
Ross, E.M.1
Roberts, W.C.2
-
11
-
-
0023840918
-
Carcinoid heart disease: Relationship of circulating vasoactive substances to ultrasound-detectable cardiac abnormalities
-
Lundin L, Norheim I, Landelius J, öberg K, Theodorsson-Norheim E: Carcinoid heart disease: relationship of circulating vasoactive substances to ultrasound-detectable cardiac abnormalities. Circulation 1988; 77: 264-269. (Pubitemid 18060033)
-
(1988)
Circulation
, vol.77
, Issue.2
, pp. 264-269
-
-
Lundin, L.1
Norheim, I.2
Landelius, J.3
Oberg, K.4
Theodorsson-Norheim, E.5
-
12
-
-
0029147358
-
Carcinoid heart disease. Correlation of high serotonin levels with valvular abnormalities detected by cardiac catheterization and echocardiography
-
Robiolio PA, Rigolin VH, Wilson JS, Harrison JK, Sanders LL, Bashore TM, Feldman JM: Carcinoid heart disease. Correlation of high serotonin levels with valvular abnormalities detected by cardiac catheterization and echocardiography. Circulation 1995; 92: 790-795.
-
(1995)
Circulation
, vol.92
, pp. 790-795
-
-
Robiolio, P.A.1
Rigolin, V.H.2
Wilson, J.S.3
Harrison, J.K.4
Sanders, L.L.5
Bashore, T.M.6
Feldman, J.M.7
-
13
-
-
0037378532
-
Carcinoid heart disease: The role of urinary 5-hydroxyindoleacetic acid excretion and plasma levels of atrial natriuretic peptide, transforming growth factor-β and fibroblast growth factor
-
DOI 10.1002/cncr.11226
-
Zuetenhorst JM, Bonfrer JM, Korse CM, Bakker R, van Tinteren H, Taal BG: Carcinoid heart disease: the role of urinary 5-hydroxyindoleacetic acid excretion and plasma levels of atrial natriuretic peptide, transforming growth factor-β and fibroblast growth factor. Cancer 2003; 97: 1609-1615. (Pubitemid 36350703)
-
(2003)
Cancer
, vol.97
, Issue.7
, pp. 1609-1615
-
-
Zuetenhorst, J.M.1
Bonfrer, J.M.G.M.2
Korse, C.M.3
Bakker, R.4
Van Tinteren, H.5
Taal, B.G.6
-
14
-
-
0030876952
-
Valvular heart disease associated with fenfluramine phentermine
-
DOI 10.1056/NEJM199708283370901
-
Connolly HM, Crary JL, McGoon MD, Hensrud DD, Edwards BS, Edwards WD, Schaf HV: Valvular heart disease associated with fenfluramine-phentermine. N Engl J Med 1997; 337: 581-588. (Pubitemid 27360757)
-
(1997)
New England Journal of Medicine
, vol.337
, Issue.9
, pp. 581-588
-
-
Connolly, H.M.1
Crary, J.L.2
McGoon, M.D.3
Hensrud, D.D.4
Edwards, B.S.5
Edwards, W.D.6
Schaff, H.V.7
-
15
-
-
0025273121
-
Mitral and aortic valve disease associated with ergotamine therapy for migraine. Report of two cases and review of literature
-
Hauck AJ, Edwards WD, Danielson GK, Mullany CJ, Bresnahan DR: Mitral and aortic valve disease associated with ergotamine therapy for migraine. Report of two cases and review of literature. Arch Pathol Lab Med 1990; 114: 62-64. (Pubitemid 20103511)
-
(1990)
Archives of Pathology and Laboratory Medicine
, vol.114
, Issue.1
, pp. 62-64
-
-
Hauck, A.J.1
Edwards, W.D.2
Danielson, G.K.3
Mullany, C.J.4
Bresnahan, D.R.5
-
16
-
-
33845986031
-
Dopamine agonists and the risk of cardiac-valve regurgitation
-
Schade R, Andersohn F, Suissa S, Haverkamp W, Garbe E: Dopamine agonists and the risk of cardiac-valve regurgitation. N Engl J Med 2007; 356: 29-38. (Pubitemid 46041751)
-
(2007)
New England Journal of Medicine
, vol.356
, Issue.1
, pp. 29-38
-
-
Schade, R.1
Andersohn, F.2
Suissa, S.3
Haverkamp, W.4
Garbe, E.5
-
17
-
-
20144389923
-
Long-term serotonin administration induces heart valve disease in rats
-
DOI 10.1161/01.CIR.0000159356.42064.48
-
Gustafsson BI, Tømmerås K, Nordrum I, Loennechen JP, Brunsvik A, Solligård E, Fossmark R, Bakke I, Syversen U, Waldum H: Long-term serotonin administration induces heart valve disease in rats. Circulation 2005; 111: 1517-1522. (Pubitemid 40470647)
-
(2005)
Circulation
, vol.111
, Issue.12
, pp. 1517-1522
-
-
Gustafsson, B.I.1
Tommeras, K.2
Nordrum, I.3
Loennechen, J.P.4
Brunsvik, A.5
Solligard, E.6
Fossmark, R.7
Bakke, I.8
Syversen, U.9
Waldum, H.10
-
18
-
-
0033058738
-
Summing up 15 years of somatostatin analog therapy in neuroendocrine tumors: Future outlook
-
Eriksson B, öberg K: Summing up 15 years of somatostatin analog therapy in neuroendocrine tumors: future outlook. Ann Oncol 1999; 10(suppl 2):S31-S38. (Pubitemid 29288528)
-
(1999)
Annals of Oncology
, vol.10
, Issue.SUPPL. 2
-
-
Eriksson, B.1
Oberg, K.2
-
19
-
-
0036838772
-
Pathogenesis of fibrosis: Role of TGF-β and CTGF
-
DOI 10.1097/00002281-200211000-00009
-
Ihn H: Pathogenesis of fibrosis: role of TGF-β and CTGF. Curr Opin Rheumatol 2002; 14: 681-685. (Pubitemid 35191556)
-
(2002)
Current Opinion in Rheumatology
, vol.14
, Issue.6
, pp. 681-685
-
-
Ihn, H.1
-
20
-
-
2142646426
-
TGF-β signaling and the fibrotic response
-
Leask A, Abraham DJ: TGF-β signaling and the fibrotic response. FASEB J 2004; 18: 816-827.
-
(2004)
FASEB J
, vol.18
, pp. 816-827
-
-
Leask, A.1
Abraham, D.J.2
-
21
-
-
0141869043
-
Activin A is an autocrine activator of rat pancreatic stellate cells: Potential therapeutic role of follistatin for pancreatic fibrosis
-
DOI 10.1136/gut.52.10.1487
-
Ohnishi N, Miyata T, Ohnishi H, Yasuda H, Tamada K, Ueda N, Mashima H, Sugano K: Activin A is an autocrine activator of rat pancreatic stellate cells: potential therapeutic role of follistatin for pancreatic fibrosis. Gut 2003; 52: 1487-1493. (Pubitemid 37176730)
-
(2003)
Gut
, vol.52
, Issue.10
, pp. 1487-1493
-
-
Ohnishi, N.1
Miyata, T.2
Ohnishi, H.3
Yasuda, H.4
Tamada, K.5
Ueda, N.6
Mashima, H.7
Sugano, K.8
-
22
-
-
0036120427
-
RANK ligand and osteoprotegerin: Paracrine regulators of bone metabolism and vascular function
-
DOI 10.1161/01.ATV.0000012303.37971.DA
-
Schoppet M, Preissner KT, Hofbauer LC: RANK ligand and osteoprotegerin: paracrine regulators of bone metabolism and vascular function. Arterioscler Thromb Vasc Biol 2002; 22: 549-553. (Pubitemid 34408732)
-
(2002)
Arteriosclerosis, Thrombosis, and Vascular Biology
, vol.22
, Issue.4
, pp. 549-553
-
-
Schoppet, M.1
Preissner, K.T.2
Hofbauer, L.C.3
-
23
-
-
4644356541
-
Activin: An important regulator of wound repair, fibrosis, and neuroprotection
-
DOI 10.1016/j.mce.2004.07.011, PII S0303720704003041, Proceedings of the International Workshop on Inhibins
-
Sulyok S, Wankell M, Alzheimer C, Werner S: Activin: an important regulator of wound repair, fibrosis, and neuroprotection. Mol Cell Endocrinol 2004; 225: 127-132. (Pubitemid 39297062)
-
(2004)
Molecular and Cellular Endocrinology
, vol.225
, Issue.1-2
, pp. 127-132
-
-
Sulyok, S.1
Wankell, M.2
Alzheimer, C.3
Werner, S.4
-
24
-
-
3142619579
-
Activins, myostatin and related TGF-β family members as novel therapeutic targets for endocrine, metabolic and immune disorders
-
Tsuchida K: Activins, myostatin and related TGF- βfamily members as novel therapeutic targets for endocrine, metabolic and immune disorders. Curr Drug Targets Immune Endocr Metabol Disord 2004; 4: 157-166.
-
(2004)
Curr Drug Targets Immune Endocr Metabol Disord
, vol.4
, pp. 157-166
-
-
Tsuchida, K.1
-
25
-
-
0346734165
-
Activin A Is a Potent Activator of Renal Interstitial Fibroblasts
-
DOI 10.1097/01.ASN.0000103225.68136.E6
-
Yamashita S, Maeshima A, Kojima I, Nojima Y: Activin A is a potent activator of renal interstitial fibroblasts. J Am Soc Nephrol 2004; 15: 91-101. (Pubitemid 38020701)
-
(2004)
Journal of the American Society of Nephrology
, vol.15
, Issue.1
, pp. 91-101
-
-
Yamashita, S.1
Maeshima, A.2
Kojima, I.3
Nojima, Y.4
-
26
-
-
1642365737
-
Role of matrix metalloproteinases in hypertension-associated cardiac fibrosis
-
DOI 10.1097/00041552-200403000-00008
-
Lopez B, Gonzalez A, Diez J: Role of matrix metalloproteinases in hypertension-associated cardiac fibrosis. Curr Opin Nephrol Hypertens 2004; 13: 197-204. (Pubitemid 38373142)
-
(2004)
Current Opinion in Nephrology and Hypertension
, vol.13
, Issue.2
, pp. 197-204
-
-
Lopez, B.1
Gonzalez, A.2
Diez, J.3
-
27
-
-
0035210701
-
Increased serum osteoprotegerin in disorders characterized by persistent immune activation or glucocorticoid excess - Possible role in bone homeostasis
-
Ueland T, Bollerslev J, Godang K, Muller F, Froland SS, Aukrust P: Increased serum osteoprotegerin in disorders characterized by persistent immune activation or glucocorticoid excess - possible role in bone homeostasis. Eur J Endocrinol 2001; 145: 685-690. (Pubitemid 33133673)
-
(2001)
European Journal of Endocrinology
, vol.145
, Issue.6
, pp. 685-690
-
-
Ueland, T.1
Bollerslev, J.2
Godang, K.3
Muller, F.4
Froland, S.S.5
Aukrust, P.6
-
28
-
-
0036288459
-
Development of ELISA on microplate for serum C-reactive protein and establishment of age-dependent normal reference range
-
Wu TL, Tsao KC, Chang CP, Li CN, Sun CF, Wu JT: Development of ELISA on microplate for serum C-reactive protein and establishment of age-dependent normal reference range. Clin Chim Acta 2002; 322: 163-168.
-
(2002)
Clin Chim Acta
, vol.322
, pp. 163-168
-
-
Wu, T.L.1
Tsao, K.C.2
Chang, C.P.3
Li, C.N.4
Sun, C.F.5
Wu, J.T.6
-
29
-
-
0033843657
-
Tumor markers in neuroendocrine tumors
-
Eriksson B, öberg K, Stridsberg M: Tumor markers in neuroendocrine tumors. Digestion 2000; 62: 33-38. (Pubitemid 30665937)
-
(2000)
Digestion
, vol.62
, Issue.SUPPL. 1
, pp. 33-38
-
-
Eriksson, B.1
Oberg, K.2
Stridsberg, M.3
-
30
-
-
34250836735
-
ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
-
Bonow RO, Carabello BA, Chatterjee K, de Leon AC Jr, Faxon DP, Freed MD, Gaasch WH, Lytle BW, Nishimura RA, O'Gara PT, O'Rourke RA, Otto CM, Shah PM, Shanewise JS, Smith SC Jr, Jacobs AK, Adams CD, Anderson JL, Antman EM, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Page RL, Riegel B: ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2006; 48:e1-e148.
-
(2006)
J Am Coll Cardiol
, vol.48
-
-
Bonow, R.O.1
Carabello, B.A.2
Chatterjee, K.3
De Leon Jr., A.C.4
Faxon, D.P.5
Freed, M.D.6
Gaasch, W.H.7
Lytle, B.W.8
Nishimura, R.A.9
O'Gara, P.T.10
O'Rourke, R.A.11
Otto, C.M.12
Shah, P.M.13
Shanewise, J.S.14
Smith Jr., S.C.15
Jacobs, A.K.16
Adams, C.D.17
Anderson, J.L.18
Antman, E.M.19
Fuster, V.20
Halperin, J.L.21
Hiratzka, L.F.22
Hunt, S.A.23
Page, R.L.24
Riegel, B.25
more..
-
31
-
-
0142008980
-
Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and doppler echocardiography
-
DOI 10.1016/S0894-7317(03)00335-3
-
Zoghbi WA, Enriquez-Sarano M, Foster E, Grayburn PA, Kraft CD, Levine RA, Nihoyannopoulos P, Otto CM, Quinones MA, Rakowski H, Stewart WJ, Waggoner A, Weissman NJ: Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr 2003; 16: 777-802. (Pubitemid 37391035)
-
(2003)
Journal of the American Society of Echocardiography
, vol.16
, Issue.7
, pp. 777-802
-
-
Zoghbi, W.A.1
Enriquez-Sarano, M.2
Foster, E.3
Grayburn, P.A.4
Kraft, C.D.5
Levine, R.A.6
Nihoyannopoulos, P.7
Otto, C.M.8
Quinones, M.A.9
Rakowski, H.10
Stewart, W.J.11
Waggoner, A.12
Weissman, N.J.13
-
32
-
-
3042715620
-
Role of natriuretic peptides in the diagnosis and treatment of patients with carcinoid heart disease
-
Zuetenhorst JM, Korse CM, Bonfrer JM, Bakker RH, Taal BG: Role of natriuretic peptides in the diagnosis and treatment of patients with carcinoid heart disease. Br J Cancer 2004; 90: 2073-2079. (Pubitemid 38869708)
-
(2004)
British Journal of Cancer
, vol.90
, Issue.11
, pp. 2073-2079
-
-
Zuetenhorst, J.M.1
Korse, C.M.2
Bonfrer, J.M.G.3
Bakker, R.H.4
Taal, B.G.5
-
34
-
-
0021070824
-
Treatment of the carcinoid tumor and the malignant carcinoid syndrome
-
Moertel CG: Treatment of the carcinoid tumor and the malignant carcinoid syndrome. J Clin Oncol 1983; 1: 727-740. (Pubitemid 14202073)
-
(1983)
Journal of Clinical Oncology
, vol.1
, Issue.11
, pp. 727-740
-
-
Moertel, C.G.1
-
35
-
-
0036486076
-
Regulation of cell proliferation, apoptosis, and carcinogenesis by activin
-
Chen YG, Lui HM, Lin SL, Lee JM, Ying SY: Regulation of cell proliferation, apoptosis, and carcinogenesis by activin. Exp Biol Med 2002; 227: 75-87.
-
(2002)
Exp Biol Med
, vol.227
, pp. 75-87
-
-
Chen, Y.G.1
Lui, H.M.2
Lin, S.L.3
Lee, J.M.4
Ying, S.Y.5
-
36
-
-
0024538542
-
Plasma atrial natriuretic peptide in carcinoid heart disease
-
DOI 10.1016/0002-9149(89)90150-1
-
Lundin L, öberg K, Landelius J, Hansson HE, Wilander E, Theodorsson E: Plasma atrial natriuretic peptide in carcinoid heart disease. Am J Cardiol 1989; 63: 969-972. (Pubitemid 19105136)
-
(1989)
American Journal of Cardiology
, vol.63
, Issue.13
, pp. 969-972
-
-
Lundin, L.1
Oberg, K.2
Landelius, J.3
Hansson, H.E.4
Wilander, E.5
Theodorsson, E.6
-
37
-
-
52349085756
-
Usefulness of N-terminal probrain natriuretic peptide as a biomarker of the presence of carcinoid heart disease
-
Bhattacharyya S, Toumpanakis C, Caplin ME, Davar J: Usefulness of N-terminal probrain natriuretic peptide as a biomarker of the presence of carcinoid heart disease. Am J Cardiol 2008; 102: 938-942.
-
(2008)
Am J Cardiol
, vol.102
, pp. 938-942
-
-
Bhattacharyya, S.1
Toumpanakis, C.2
Caplin, M.E.3
Davar, J.4
-
38
-
-
46249090767
-
Natriuretic peptides: An update on bioactivity, potential therapeutic use, and implication in cardiovascular diseases
-
DOI 10.1038/ajh.2008.174, PII AJH2008174
-
Rubattu S, Sciarretta S, Valenti V, Stanzione R, Volpe M: Natriuretic peptides: an update on bioactivity, potential therapeutic use, and implication in cardiovascular diseases. Am J Hypertens 2008; 21: 733-741. (Pubitemid 351913612)
-
(2008)
American Journal of Hypertension
, vol.21
, Issue.7
, pp. 733-741
-
-
Rubattu, S.1
Sciarretta, S.2
Valenti, V.3
Stanzione, R.4
Volpe, M.5
-
39
-
-
12144285683
-
Elevated levels of activin a in heart failure: Potential role in myocardial remodeling
-
DOI 10.1161/01.CIR.0000120704.97934.41
-
Yndestad A, Ueland T, øie E, Florholmen G, Halvorsen B, Attramadal H, Simonsen S, Frøland SS, Gullestad L, Christensen G, Damås JK, Aukrust P: Elevated levels of activin A in heart failure: potential role in myocardial remodeling. Circulation 2004; 109: 1379-1385. (Pubitemid 38387824)
-
(2004)
Circulation
, vol.109
, Issue.11
, pp. 1379-1385
-
-
Yndestad, A.1
Ueland, T.2
Oie, E.3
Florholmen, G.4
Halvorsen, B.5
Attramadal, H.6
Simonsen, S.7
Froland, S.S.8
Gullestad, L.9
Christensen, G.10
Damas, J.K.11
Aukrust, P.12
-
40
-
-
29544448270
-
Activin A is an acute allergen-responsive cytokine and provides a link to TGF-β-mediated airway remodeling in asthma
-
DOI 10.1016/j.jaci.2005.09.017, PII S0091674905020658
-
Karagiannidis C, Hense G, Martin C, Epstein M, Rückert B, Mantel PY, Menz G, Uhlig S, Blaser K, Schmidt-Weber CB: Activin A is an acute allergen-responsive cytokine and provides a link to TGF-β -mediated airway remodeling in asthma. J Allergy Clin Immunol 2006; 117: 111-118. (Pubitemid 43017148)
-
(2006)
Journal of Allergy and Clinical Immunology
, vol.117
, Issue.1
, pp. 111-118
-
-
Karagiannidis, C.1
Hense, G.2
Martin, C.3
Epstein, M.4
Ruckert, B.5
Mantel, P.-Y.6
Menz, G.7
Uhlig, S.8
Blaser, K.9
Schmidt-Weber, C.B.10
-
41
-
-
0029950962
-
Serum immunoreactive activin A levels in normal subjects and patients with various diseases
-
DOI 10.1210/jc.81.6.2125
-
Harada K, Shintani Y, Sakamoto Y, Wakatsuki M, Shitsukawa K, Saito S: Serum immunoreactive activin A levels in normal subjects and patients with various diseases. J Clin Endocrinol Metabol 1996; 81: 2125-2130. (Pubitemid 26176707)
-
(1996)
Journal of Clinical Endocrinology and Metabolism
, vol.81
, Issue.6
, pp. 2125-2130
-
-
Harada, K.1
Shintani, Y.2
Sakamoto, Y.3
Wakatsuki, M.4
Shitsukawa, K.5
Saito, S.6
-
42
-
-
0036095708
-
Serum and tissue expression of activin A in postmenopausal women with breast cancer
-
DOI 10.1210/jc.87.5.2277
-
Reis FM, Cobellis L, Tameirão LC, Anania G, Luisi S, Silva IS, Gioffrè W, di Blasio AM, Petraglia F: Serum and tissue expression of activin a in postmenopausal women with breast cancer. J Clin Endocrinol Metabol 2002; 87: 2277-2282. (Pubitemid 34521520)
-
(2002)
Journal of Clinical Endocrinology and Metabolism
, vol.87
, Issue.5
, pp. 2277-2282
-
-
Reis, F.M.1
Cobellis, L.2
Tameirao, L.C.3
Anania, G.4
Luisi, S.5
Silva, I.S.B.6
Gioffre, W.7
Di Blasio, A.M.8
Petraglia, F.9
-
43
-
-
0030670883
-
Presence of activin, inhibin, and follistatin in epithelial ovarian carcinoma
-
Welt CK, Lambert-Messerlian G, Zheng W, Crowley WF Jr, Schneyer AL: Presence of activin, inhibin, and follistatin in epithelial ovarian carcinoma. J Clin Endocrinol Metabol 1997; 82: 3720-3727. (Pubitemid 27509361)
-
(1997)
Journal of Clinical Endocrinology and Metabolism
, vol.82
, Issue.11
, pp. 3720-3727
-
-
Welt, C.K.1
Lambert-Messerlian, G.2
Zheng, W.3
Crowley Jr., W.F.4
Schneyer, A.L.5
-
44
-
-
0033005683
-
Immunohistochemical localization of α- and βA-subunits of inhibin/activin in human normal endocrine cells and related tumors of the digestive system
-
DOI 10.1007/s004280050301
-
La Rosa S, Uccella S, Billo P, Facco C, Sessa F, Capella C: Immunohistochemical localization of α - and β A-subunits of inhibin/activin in human normal endocrine cells and related tumors of the digestive system. Virchows Arch 1999; 434: 29-36. (Pubitemid 29184899)
-
(1999)
Virchows Archiv
, vol.434
, Issue.1
, pp. 29-36
-
-
La Rosa, S.1
Uccella, S.2
Billo, P.3
Facco, C.4
Sessa, F.5
Capella, C.6
-
45
-
-
0742287917
-
Localization of inhibins and activins in normal endocrine cells and endocrine tumors of the gut and pancreas: An immunohistochemical and in situ hybridization study
-
La Rosa S, Uccella S, Marchet S, Capella C, Lloyd RV: Localization of inhibins and activins in normal endocrine cells and endocrine tumors of the gut and pancreas: an immunohistochemical and in situ hybridization study. J Histochem Cytochem 2004; 52: 217-225. (Pubitemid 38146581)
-
(2004)
Journal of Histochemistry and Cytochemistry
, vol.52
, Issue.2
, pp. 217-225
-
-
La Rosa, S.1
Uccella, S.2
Marchet, S.3
Capella, C.4
Lloyd, R.V.5
-
46
-
-
33748579926
-
The autocrine effect of activin A on human ovarian clear cell adenocarcinoma cells
-
Mabuchi Y, Yamoto M, Minami S, Umesaki N: The autocrine effect of activin A on human ovarian clear cell adenocarcinoma cells. Oncol Rep 2006; 16: 373-379.
-
(2006)
Oncol Rep
, vol.16
, pp. 373-379
-
-
Mabuchi, Y.1
Yamoto, M.2
Minami, S.3
Umesaki, N.4
-
47
-
-
0034120715
-
Mitogenic and secretory responses of human valve interstitial cells to vasoactive agents
-
Hafizi S, Taylor PM, Chester AH, Allen SP, Yacoub MH: Mitogenic and secretory responses of human valve interstitial cells to vasoactive agents. J Heart Valve Dis 2000; 9: 454-458. (Pubitemid 30395140)
-
(2000)
Journal of Heart Valve Disease
, vol.9
, Issue.3
, pp. 454-458
-
-
Hafizi, S.1
Taylor, P.M.2
Chester, A.H.3
Allen, S.P.4
Yacoub, M.H.5
-
48
-
-
0036899272
-
2 receptor and its signaling pathway in aortic valve interstitial cells
-
Xu J, Jian B, Chu R, Lu Z, Li Q, Dunlop J, Rosenzweig-Lipson S, McGonigle P, Levy RF, Liang B: Serotonin mechanisms in heart valve disease II: the 5-HT 2 receptor and its signaling pathway in aortic valve interstitial cells. Am J Pathol 2002; 161: 2209-2218. (Pubitemid 35434865)
-
(2002)
American Journal of Pathology
, vol.161
, Issue.6
, pp. 2209-2218
-
-
Xu, J.1
Jian, B.2
Chu, R.3
Lu, Z.4
Li, Q.5
Dunlop, J.6
Rosenzweig-Lipson, S.7
McGonigle, P.8
Levy, R.J.9
Liang, B.10
|